EDC
One size does not fit all
Safety Notification
RTSM
Deliver powerful randomization methods
CODER
Fast and accurate clinical coding
Drug and Device Logistics
Mitigate risk and create closer connections
eTMF
Essential document collection
CTMS
Accelerate your trial and ensure data integrity
eCONSENT
Meet patients where they are
eCOA
Faster, cleaner and more reliable data
Patient Poll
Quick insights from patients
eCRF Setup
Capture better data, faster
eTMF Setup
Get up and running in no time
PV Management
Identify and handle your safety management needs
Data Management
Make more informed business decisions
Managed Service Model for MDR
Migration, Consulting and Customization for your MDR
Submission and Data Mapping
Move and consolidate data
eTechnology Strategy
Integrate and capitalize on critical technologies
Protocol Development
Turning your research question into a study
Observational Studies
Digital, cost effective and time efficient
Primary Market Research
Direct to patient, unique, and quality data
IRB and EC Management
End to end regulatory management
PV and GDPR Compliance
Safety, consent and data protection
Scientific Communications
Results dissemination
Digital Communications
Increase patient awareness
Data Linkage
Generate, combine and analyze data
EvidentIQ, the innovative provider of advanced clinical trial management solutions has joined forces with Quinta Analytica, a renowned GCP/GLP/GMP-certified European CRO and part of the
Carenity, a prominent patient-centric company and member of the EvidentIQ Group, announces a change in its leadership. Michael Chekroun, founder of Carenity and outgoing President, will be
EvidentIQ launches a new Managed Service Model that not only supports the use of the open-source solution OpenStudyBuilder, but also helps clients customizing it to
January 9th, 2023, Hamburg (GERMANY). They will leverage best-in-class technologies, data science and clinical research expertise to digitally streamline clinical trials. Today, EvidentIQ, a leading
July 4th, 2022, Hamburg (GERMANY). This merger will strengthen their portfolio and help bring EvidentIQ’s offer to yet another level of expertise. Today, EvidentIQ, a leading
April 21st, 2022, Hamburg (GERMANY). EvidentIQ joins forces with Novo Nordisk, Neo4j, and Microsoft, to bring a new solution for managing clinical data standards and
EvidentIQ Group GmbH Rathausmarkt 5, 20095 Hamburg, Germany.
Copyright 2023 EvidentIQ
All Rights Reserved
Commercial Register: Hamburg HRB 147319
Sales Tax Identification Number: DE312852940
Managing Directors
Andreas Weber, Manuel Neukum, Axel Jansen, Lars Kloppsteck,
Helge Hofmeister
Commercial Register: Hamburg, HRB 147319
Sales tax identification number: DE312852940
Commercial Register: Hamburg, HRB 147319
Sales tax identification number: DE312852940
Follow us:
